Imagine a vaccine that is created without using a living organism…
… that is rapidly developed using a ”plug-and-play” technology
… that is stable at room temperature
… that can be self-administered without needles
… that can be applied mucosally to induce broad protection
… that can be multi-valent
… that can be easily manufactured using a ”plug-and play” technology
… that can be scaled to produce 100+ million doses per month
Imagine a company that is developing such vaccines for both human and veterinary applications.
That company is GalenBio Incorporated.
GalenBio develops vaccines for the prevention and treatment of infections, chronic diseases and cancer.